Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3858 results

Sort By:

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT07311694
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

370

Intervention / Treatment

HRS-4357 injection

Enzalutamide；Abiraterone

Sponsor

Jiangsu H鞥R UI medicine co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Tele-PCIT for Healthy Relationships in Families At-Risk

Study ID: NCT07225010
Start Date: 2026-01
End Date: 2028-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Telehealth Parent Child Interaction Therapy

Telehealth Parent Child Interaction Therapy (Delayed Start)

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Evaluation Of Cardiovascular Health Outcomes Among Survivors 2

Study ID: NCT07245420
Start Date: 2026-01
End Date: 2030-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment

Survivorship Care Plan + Educational Materials (delivered via CIAS platform)

Healthy Hearts eHealth Program

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

PNS vs RFA for Facet Joint Pain

Study ID: NCT05952518
Start Date: 2026-02-20
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Sprint PNS system

Radiofrequency Ablation

Sponsor

Penn State University

Source: clinicaltrials.gov

Share:
Add to list

Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

Study ID: NCT06595940
Start Date: 2026-01-05
End Date: 2034-08-21
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment
Sponsor

National Human Genome Research Institute (NHGRI)

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin to Treat Depression in Spinal Cord Injury

Study ID: NCT07251491
Start Date: 2026-01-01
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Psilocybin (American Institute)

Sponsor

James J. Peters Veterans Affairs Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia

Study ID: NCT07311343
Start Date: 2026-01-01
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

440

Intervention / Treatment

wether apply enhanced oral care combined with prophylactic antibiotics

Sponsor

Beijing Tia Ntanhospital

Source: clinicaltrials.gov

Share:
Add to list

A Sleep Intervention for Preschoolers in Foster Care

Study ID: NCT06549491
Start Date: 2026-09-01
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

Sleep Wizard

Sponsor

Bradley Hospital

Source: clinicaltrials.gov

Share:
Add to list

Promoting Maintenance of Change Following Brief Intervention for Alcohol Use

Study ID: NCT05712382
Start Date: 2026-09
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Parent handbook

Coping with negative emotions

Problem-solving risky situations

Recovering from slips

Sponsor

University of Massachusetts, Amherst

Source: clinicaltrials.gov

Share:
Add to list

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Study ID: NCT07288359
Start Date: 2026-03-16
End Date: 2031-05-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

205

Intervention / Treatment

Gvv858

Fulvestrant

Letrozole

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list